With the analysis among 595 patents, we discovered top 87 key players by total patent application. H. Lundbeck A/S, UCB Biopharma SRL, Bial R&d Investments SA are dominant in this area. They take 25.55% of the total patent filing.
Hovedstaden, Denmark
Patent: 56
Lysosomal Therapeutics, Inc.
Massachusetts, United States
Patent: 26
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 25
Neuropore Therapies, Inc.
California, United States
Patent: 23
Central Singapore, Singapore
Patent: 20
Ionis Pharmaceuticals, Inc.
California, United States
Patent: 16
Sangamo Therapeutics, Inc.
California, United States
Patent: 14
Vlaams-Brabant, Belgium
Patent: 14
With the analysis among 14 patents, we discovered top 6 start-ups by total patent application. Standigm Co. Ltd., Chase Therapeutics Corp., Biosplice Therapeutics, Inc. are active in this area.
District of Columbia, United States
Patent: 4
Biosplice Therapeutics, Inc.
California, United States
Patent: 1
Institut National de la Santé et de la Recherche Médicale
Pennsylvania, United States
Patent: 1
With the analysis among related 249 patents applied in the last 5 years. We discover 60 most active companies in this area. The fast-growing UCB Biopharma SRL, H. Lundbeck A/S, Ionis Pharmaceuticals, Inc. take 26.91% of patent filing during this period.
Hovedstaden, Denmark
Patent: 23
Ionis Pharmaceuticals, Inc.
California, United States
Patent: 16
Sangamo Therapeutics, Inc.
California, United States
Patent: 14
Takeda Pharmaceutical Co., Ltd.
Osaka-fu, Japan
Patent: 13
Biohaven Therapeutics Ltd.
British Virgin Islands
Patent: 9
Biogen International Neuroscience GmbH
ZURICH, Switzerland
Patent: 7
Ajou University Industry-Academic Cooperation Foundation
Lysosomal Therapeutics, Inc.
Massachusetts, United States
Patent: 6
With the analysis among related 249 patents in last 5 years, we discover 45 new entrants. Ionis Pharmaceuticals, Inc., Sangamo Therapeutics, Inc., Takeda Pharmaceutical Co., Ltd. are the most active new entrants in this area.
Ionis Pharmaceuticals, Inc.
California, United States
Patent: 16
Sangamo Therapeutics, Inc.
California, United States
Patent: 14
Takeda Pharmaceutical Co., Ltd.
Osaka-fu, Japan
Patent: 13
Biohaven Therapeutics Ltd.
British Virgin Islands
Patent: 9
Biogen International Neuroscience GmbH
ZURICH, Switzerland
Patent: 7
Shire Human Genetic Therapies, Inc.
Massachusetts, United States
Patent: 5
Illinois, United States
Patent: 5
Manchester, United Kingdom
Patent: 4
With the analysis among 89 patents, we discovered top 28 universities and scientific research institutions by total patent application. The Trustees of Columbia University in The City of New York, Northwestern University, The University of Sydney are dominant in this area. They take 23.60% of the total patent filing.
The Trustees of Columbia University in The City of New York
New York, United States
Patent: 5
Illinois, United States
Patent: 5
Steiermark, Austria
Patent: 5
Katholieke Universiteit Leuven
Vlaams-Brabant, Belgium
Patent: 4
Beijing Shi, China
Patent: 2